While OLFM4’s oncogenic functions have been characterized in various malignancies, including its established role as a metastasis marker in ER+ breast cancer [29] and its association with cancer stem cell properties in hepatocellular carcinoma [30], its specific contributions to HNSCC pathogenesis remain underexplored. The gene discussed is OLFM4; the disease is breast carcinoma.